U.S., July 19 -- ClinicalTrials.gov registry received information related to the study (NCT07073729) titled 'Corneal Neurotization vs. Cenergermin for Neurotrophic Keratitis: A Pilot Study' on July 09.
Brief Summary: This pilot study evaluates the feasibility and outcomes of two treatment approaches for corneal sensory dysfunction due to neurotrophic keratitis (NK): corneal neurotization surgery and topical Cenergermin (Oxervate). Participants will receive treatment based on clinical decision-making, not randomization, and will be followed for 12 months through eight visits at the Ivey Eye Institute, St. Joseph's Health Care London. Data collected during routine eye examinations and validated quality-of-life questionnaires will be used to ...